Genetic Medicine

The Genetic Medicine Department is dedicated to researching genetic therapies and personalized medicine. Patients are at the forefront of the department’s research, which involves using information from an individual’s genotype to create a medicine or therapy specifically for that patient. Trials include gene therapy for cystic fibrosis, cardiac ischemia and central nervous system disorders. The department’s translational research program involves collaborations with institutions nearby and abroad, including Weill Cornell Medicine-Qatar. Recent projects study gene transfer strategies for cancer patients and the role of cancer stem cells in lung cancer. 


Innovative Imaging Technology Effectively Measures Disease Severity in Rare Neurodegenerative Disorder

January 15, 2019

A rapid, non-invasive eye exam that uses innovative imaging technology effectively measures the severity of disease in patients with a rare neurodegenerative disease called...
Weill Cornell and Drug Maker UCB Strike Strategic Alliance

April 3, 2014

Weill Cornell Medical College and drug maker UCB have teamed up to translate innovative Weill Cornell-led research in bone disorders, metabolic disease and genetics into next-...